The global drug formulation market was valued at over $1.5T in 2021 and is expected to grow at a CAGR of 5.6% by 2032, according to a report by Future Market Insights.
The oral formulation is expected to hold a 44.6% market value share by the end of 2032.
Based on various indications, central nervous systems disorders hold the highest market share at 14.1% in 2021 and are projected to dominate throughout the forecast period.
In terms of end-user, the big pharma companies are expected to register a CAGR of 5.1% in upcoming years. North America is slated to be the leading region with a value share of 48.1% at the end of the forecast period.